The legality question with the layered answer — because in 2026 the US answer has a federal row, a state row, and a pending row, and all three have to be read.
The short answer
As of September 2026, 7-hydroxymitragynine is not federally scheduled — while a federal threshold rule is pending — and the state row is the one that decides your specific answer: seven states have restricted the product or its category (Florida, Virginia, Tennessee, Kansas, North Dakota for 7-OH specifically; Louisiana for kratom broadly; Massachusetts via emergency order). The combined read, dated, is the legal status guide, the state map is in the state overview, and the federal three-row table is in the federal status guide.
The three rows, in the order a buyer reads them
Row one — state: the map is step one, because a state restriction applies regardless of the federal status, and the restricted list is enforced at checkout in the shipping policy (the state-by-state posts are in the blog’s Legal cluster). Row two — federal, current: the DEA’s August 26, 2026 action scheduled mitragynine pseudoindoxyl, MGM-15, and MGM-16 on temporary Schedule I — related compounds, not 7-OH itself, which is why the related-compound screens are in the batch panel (the DEA update is the record). Row three — federal, pending: the 7-OH threshold rule, notice July 6, 2026, not yet in effect — the one item that would change the answer in every state at once. The habit that keeps a buyer correct across all three rows: check the map, check the federal overlay, verify the batch COA, and re-check on process milestones — the 9-point checklist is the structured version, and the FAQ center carries the standing legality questions. This page is general information, not legal advice; a licensed professional is the source for a specific situation.
Related reading
- Platinum 100mg — permitted addresses only
- Black Edition 50mg — permitted addresses only
- The state map: step one
- The federal three-row table
- Back to the full FAQ hub — all 50 answers
21+ adult product. General information only — not legal or medical advice. Questions? Contact us (Mon–Fri, 9am–5pm PT, +1 (213) 357-1073, [email protected]).